Afficher la notice abrégée

dc.rights.licenseopen
hal.structure.identifierUCL Healthcare Biomagnetic and Nanomaterials Laboratories
dc.contributor.authorWANG, Lilin
hal.structure.identifierUCL Healthcare Biomagnetic and Nanomaterials Laboratories
dc.contributor.authorHERVAULT, Aziliz
hal.structure.identifierUCL Healthcare Biomagnetic and Nanomaterials Laboratories
dc.contributor.authorSOUTHERN, Paul
hal.structure.identifierLaboratoire de Chimie des Polymères Organiques [LCPO]
dc.contributor.authorSANDRE, Olivier
hal.structure.identifierImagerie moléculaire et thérapies innovantes en oncologie [IMOTION]
dc.contributor.authorCOUILLAUD, Franck
hal.structure.identifierUCL Healthcare Biomagnetic and Nanomaterials Laboratories
dc.contributor.authorTHANH, Nguyen Thi Kim
dc.date.accessioned2020
dc.date.available2020
dc.date.issued2020
dc.identifier.issn2050-750X
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/19554
dc.description.abstractEnNanoparticle induced hyperthermia has been considered as a promising approach for cancer treatment for decades. The local heating ability and drug delivery potential highlight a diversified possibility in clinical application, therefore a variety of nanoparticles that has been developed accordingly. However, currently, only a few of them have been translated into clinical stage indicating the ‘nanoparticle medically underserved’ situation, which encourages their comprehensive biomedical exploration. This study presents a thorough biological evaluation of previous well-developed dual pH- and thermo- responsive magnetic Doxorubicin-nanocarrier (MNC-DOX) in multiple cancer cell lines. The biocompatible of the nanocomposites has been proved by the MTT assay on primary cell lines. The histology and fluorescence microscopy imaging revealed the efficient but various cellular uptaking of nanocarriers among cell lines. The IC50 of MNC-DOX is significantly lower than free DOX without alternative magnetic field (AMF), which implied the potential to lower the systemic cytotoxicity in clinical research. The concurrent thermo-chemotherapy generated by this platform has been successfully achieved under alternating magnetic field (AMF). Promising effective synergistic results have been demonstrated through in vitro study in multi-model cancer cell lines via both trypan blue exclusion method and bioluminescence imaging method. Furthermore, the two most used magnetic hyperthermia modality, namely intracellular and extracellular treatments have been compared on the same nanocarriers in all 3 cell lines, which showed treatment after internalization is not required but preferable. These results lead to the conclusion that this dual responsive nanocarrier has extraordinary potential to serve as a novel broad-spectrum anticancer drug and worth to be pursued for potential clinical applications.
dc.description.sponsorshipTranslational Research and Advanced Imaging Laboratory - ANR-10-IDEX-03-02/10-LABX-0057
dc.language.isoen
dc.publisherRoyal Society of Chemistry
dc.subject.enMagnetic nanoparticles MNPs
dc.subject.enMagnetic hyperthermia
dc.subject.enDoxorubicin DOX
dc.subject.enpH-responsive polymers
dc.subject.enhuman breast carcinoma cells (MCF-7)
dc.subject.enhuman glioblastoma cells (U-87)
dc.subject.enhalf maximal inhibitory concentration (IC50)
dc.subject.ensynergistic efficiency
dc.subject.enValeriote’s statistical assay
dc.title.enIn vitro exploration of the synergistic effect of alternating magnetic field mediated thermo-chemotherapy with doxorubicin loaded dual pH- and thermo-responsive magnetic nanocomposite carriers
dc.typeArticle de revue
dc.identifier.doi10.1039/D0TB01983F
dc.subject.halChimie/Polymères
dc.subject.halPhysique [physics]/Matière Condensée [cond-mat]/Matière Molle [cond-mat.soft]
dc.subject.halSciences du Vivant [q-bio]/Cancer
dc.subject.halSciences du Vivant [q-bio]/Biologie cellulaire
dc.description.sponsorshipEuropeMultifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy
bordeaux.journalJournal of materials chemistry‎ B
bordeaux.volume8
bordeaux.hal.laboratoriesLaboratoire de Chimie des Polymères Organiques (LCPO) - UMR 5629*
bordeaux.institutionBordeaux INP
bordeaux.institutionUniversité de Bordeaux
bordeaux.peerReviewedoui
hal.identifierhal-02972310
hal.version1
hal.origin.linkhttps://hal.archives-ouvertes.fr//hal-02972310v1
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20materials%20chemistry%E2%80%8E%20B&rft.date=2020&rft.volume=8&rft.eissn=2050-750X&rft.issn=2050-750X&rft.au=WANG,%20Lilin&HERVAULT,%20Aziliz&SOUTHERN,%20Paul&SANDRE,%20Olivier&COUILLAUD,%20Franck&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée